In another study by Cercek et al., 12 patients with stage II and III dMMR/MSI-H rectal cancer who received PD-1 inhibitor therapy every 3 weeks for 6 months achieved a 100% cCR during follow-up (9). Here, PDCD1 is linked to rectal cancer.